Citation Impact
Citing Papers
p53: puzzle and paradigm.
1996 Standout
Inflammation and cancer
2002 StandoutNature
Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product
1993
Genital human papillomavirus infection in men
2005
Control of Cyclin D1 and Breast Tumorigenesis by the EglN2 Prolyl Hydroxylase
2009 StandoutNobel
Adenovirus transformation revenant resistant to retransformation by E1 but not by SV40-T and HPV16-E7 oncogenes
1992
The epidemiology of human papillomavirus infections
2005
The carcinogenicity of human papillomavirus types reflects viral evolution
2005
Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers
2000
The human papillomavirus E7 protein as a transforming and transactivating factor
1993
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
2000 Standout
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
Inactivation of Interferon Regulatory Factor-1 Tumor Suppressor Protein by HPV E7 Oncoprotein
2000
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
1999 Standout
Choosing anticancer drug targets in the postgenomic era
1999 StandoutNobel
Classification of papillomaviruses
2004 StandoutNobel
Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells
2004 StandoutNobel
Head and neck cancer
2008 Standout
The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>
2002 Standout
Vertically transmitted nasopharyngeal infection of the human papillomavirus: Does it play an aetiological role in nasopharyngeal cancer?
2014
The Epigenomics of Cancer
2007 Standout
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Viral channel proteins in intracellular protein–protein communication: Vpu of HIV-1, E5 of HPV16 and p7 of HCV
2013
The serological response to papillomaviruses
1999
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
1999 Standout
Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue
2000 StandoutNobel
Cancer genes and the pathways they control
2004 Standout
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
Human Papillomavirus and Human Disease
1997
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Regulation of cancer cell metabolism
2011 Standout
Functions of Human Papillomavirus Proteins
1994
Human papillomavirus and cervical cancer
2007 Standout
Nasopharyngeal carcinoma
2015 Standout
A review of molecular recognition technologies for detection of biological threat agents
2000
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
2007 Standout
Human papillomavirus immortalization and transformation functions
2002
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Molecular Pathogenesis of Cancer of the Cervix and Its Causation by Specific Human Papillomavirus Types
1994 StandoutNobel
Hepatitis C Virus Nonstructural Protein NS4B Transforms NIH3T3 Cells in Cooperation with the Ha-ras Oncogene
2000
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
Biological activities and molecular targets of the human papillomavirus E7 oncoprotein
2001
The Human Papillomavirus E7 Oncoprotein Functionally Interacts with the S4 Subunit of the 26 S Proteasome
1997
Oncogenic DNA viruses
2001 StandoutNobel
DNA tumor virus transforming proteins and the cell cycle
1993
Inhibitors of mammalian G1 cyclin-dependent kinases.
1995 Standout
Infections as a major preventable cause of human cancer
2000
Do Epidermodysplasia Verruciformis Human Papillomaviruses Contribute to Malignant and Benign Epidermal Proliferations?
2002
Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression
2001 StandoutNobel
The Tumor Suppressor Protein p16 and the Human Papillomavirus Oncoprotein-58 E7 Are Naturally Occurring Lysine-less Proteins That Are Degraded by the Ubiquitin System
2004 StandoutNobel
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
1996 Standout
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth
1999
A Novel Human DnaJ Protein, hTid-1, a Homolog of the Drosophila Tumor Suppressor Protein Tid56, Can Interact with the Human Papillomavirus Type 16 E7 Oncoprotein
1998
Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis
2002 StandoutNobel
External Genital Warts: Diagnosis, Treatment, and Prevention
2002
Cellular transformation by papilomavirus oncorproteins
1993
Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex
1999 StandoutNobel
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.
1994
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
2001 StandoutNobel
Functional Nucleic Acid Sensors
2009 Standout
E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.
1996
New Approaches to Immunotherapy for HPV Associated Cancers
2011
HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes.
1994
Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation
1998
A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
1995 StandoutNobel
Retinoic acid inhibition of human papillomavirus type 16-mediated transformation of human keratinocytes.
1993
Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation
1993
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage ofMycobacterium tuberculosisHeat Shock Protein 70 Gene to an Antigen Gene
2001 StandoutNobel
Activation of the c-fos gene by the HPV16 oncoproteins depends upon the cAMP-response element at -60
1994
Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts
1993
Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models
1992 Standout
Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions
1994
Modulation of type M 2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein
1999
An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication
2004 StandoutNobel
Secondary structure determination of the conserved 98-base sequence at the 3' terminus of hepatitis C virus genome RNA
1997 StandoutNobel
The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein
1993
Application of Free-Energy Decomposition to Determine the Relative Stability of R and S Oligodeoxyribonucleotide Methylphosphonates
1991
Disturbance of Tumor Necrosis Factor Alpha-Mediated Beta Interferon Signaling in Cervical Carcinoma Cells
2002 StandoutNobel
Increased Incidence of Squamous Cell Carcinomas in Mastomys natalensis Papillomavirus E6 Transgenic Mice during Two-Stage Skin Carcinogenesis
2004 StandoutNobel
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation
1995
Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line
1995
Genital Human Papillomavirus Infection in Men
2007
E5 Protein of Human Papillomavirus Type 16 Protects Human Foreskin Keratinocytes from UV B-Irradiation-Induced Apoptosis
2002
A Synthetic E7 Gene of Human Papillomavirus Type 16 That Yields Enhanced Expression of the Protein in Mammalian Cells and Is Useful for DNA Immunization Studies
2003 StandoutNobel
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation
1993
The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors.
1996
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Disruption of epithelial cell-matrix interactions induces apoptosis
1994 Standout
Cell proteins bind specifically to West Nile virus minus-strand 3' stem-loop RNA
1996
Fluorescence Resonance Energy Transfer Between Quantum Dot Donors and Dye-Labeled Protein Acceptors
2003 StandoutNobel
Works of Barbara Kell being referenced
Perinatal infection and persistence of human papillomavirus types 16 and 18 in infants
1995
High prevalence of human papillomavirus type 16 infection among children
2000
Human papillomavirus type 16 in infants: use of DNA sequence analyses to determine the source of infection
1996
Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons
2000
Detection of E5 oncoprotein in human papillomavirus type 16-positive cervical scrapes using antibodies raised to synthetic peptides
1994
Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia.
1998
Cancer associated human papillomaviruses: perinata transmission and persistence
1994
Polymerase chain reaction protocols for the detection of DNA from mucosal human papillomavirus types -6, -11, -16, -18, -31 and -33
1997
Sequence dependent effects in methylphosphonate deoxyribonucleotide double and triple helical complexes
1990
Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes
1992
Hypothetical structure of the membrane-associated E5 oncoprotein of human papillomavirus type 16
1994